About the ESC Council of Cardio-Oncology
Who We Are
Cardio‑oncology is becoming increasingly important as more people survive cancer, more older adults require long‑term cancer treatment, and cardiovascular complications from cancer therapy continue to rise.
Our goal is simple: to reduce the risk of cardiovascular disease in people with cancer, so they can safely receive the most effective treatments – including chemotherapy, targeted therapies, hormone therapy, immunotherapy and radiotherapy – with fewer side effects and fewer interruptions to their care.
Consequently, the ESC created the Council of Cardio-Oncology in August 2018 as a multidisciplinary constituent body that supports the prevention, early detection and management of heart problems caused by cancer treatments.
Today, the council brings together over 3,000 members worldwide, supported by a team of volunteers on the Council Board.
Our vision
We aim to bring together experts from cardiology, oncology, haematology, radiotherapy and related fields to improve how cancer therapy‑related heart diseases are prevented, diagnosed and treated, and to raise the overall standard of care for cardio‑oncology patients.
We work in line with the ESC Strategic Pillars: Advocacy, Congresses, Research, Membership and Education.
What we do
The Council is active in several areas, including :
- Organising the ESC Cardio-Oncology conference
- Creating cardio-oncology educational content
- Writing position papers and consensus statements on key cardio-oncology topics
- Developing the programme for cardio-oncology sessions at ESC Congress and contributing to other ESC subspecialty congresses
- Working with the ESC Advocacy Division to help shape the EU's Beating Cancer Plan
- Producing a regular newsletter for members
More to Explore
Study Groups
ESC Council on Cardio-Oncology